Boston Scientific Corporation (BSX)
USD 88.03
(-2.65%)
USD 88.03
(-2.65%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.5 Billion | 1.52 Billion | 1.87 Billion | 1.5 Billion | 1.83 Billion | 310 Million |
| Net Income | 1.59 Billion | 698 Million | 1.04 Billion | -82 Million | 4.7 Billion | 1.67 Billion |
| Depreciation & Amortization | 1.19 Billion | 1.13 Billion | 1.09 Billion | 1.12 Billion | 1.01 Billion | 894 Million |
| Deferred income taxes | -1 Million | -63 Million | -124 Million | -82 Million | -4.3 Billion | -87 Million |
| Stock-based compensation | 233 Million | 220 Million | 194 Million | 170 Million | 157 Million | 140 Million |
| Change in working capital | -770 Million | -1 Billion | -351 Million | 42 Million | -282 Million | -2.16 Billion |
| Other non-cash items | 253 Million | 540 Million | 17 Million | 337 Million | 551 Million | -148 Million |
| Investing Cash Flow | -2.57 Billion | -2.01 Billion | -1.59 Billion | -411 Million | -5.04 Billion | -1.92 Billion |
| Investments in PPE | -800 Million | -612 Million | -554 Million | -376 Million | -461 Million | -316 Million |
| Acquisitions | -1.81 Billion | -1.53 Billion | -1.43 Billion | 12 Million | -4.29 Billion | -1.44 Billion |
| Investment purchases | -55 Million | -24 Million | 96 Million | -146 Million | -348 Million | -172 Million |
| Sales/Maturities of investments | 2 Million | 56 Million | 294 Million | 12 Million | 59 Million | 14 Million |
| Other Investing Activities | 90 Million | 106 Million | -1 Million | 87 Million | 1 Million | 1 Million |
| Financing Cash Flow | 5 Million | -548 Million | -95 Million | 293 Million | 2.97 Billion | 1.43 Billion |
| Debt repayment | -4 Million | -86 Million | - | -6.84 Billion | -3.66 Billion | -1.17 Billion |
| Dividends payments | -28 Million | -55 Million | -55 Million | -28 Million | - | - |
| Common Stock Repurchased | 182 Million | 136 Million | 110 Million | -535 Million | - | - |
| Common Stock Issuance | 182 Million | 136 Million | 110 Million | 975 Million | 123 Million | 101 Million |
| Other Financing Activities | 33 Million | -579 Million | -40 Million | 6.72 Billion | -696 Million | 2.5 Billion |
| Accounts receivables | -238 Million | -220 Million | -279 Million | 335 Million | -130 Million | -110 Million |
| Accounts payables | 118 Million | -255 Million | 408 Million | 88 Million | 111 Million | -710 Million |
| Inventory | -660 Million | -321 Million | -346 Million | -65 Million | -290 Million | -83 Million |
| Other working capital | 780 Million | -209 Million | -134 Million | -316 Million | 27 Million | -1.25 Billion |
| Cash at beginning of period | 1.12 Billion | 2.16 Billion | 1.99 Billion | 607 Million | 829 Million | 1.01 Billion |
| Cash at end of period | 1.05 Billion | 1.12 Billion | 2.16 Billion | 1.99 Billion | 607 Million | 829 Million |
| Capital Expenditure | -800 Million | -612 Million | -554 Million | -376 Million | -461 Million | -316 Million |
| Effect of forex changes on cash | -4 Million | -9 Million | -6 Million | -2 Million | 10 Million | -8 Million |
| Net cash flow / Change in cash | -71 Million | -1.04 Billion | 173 Million | 1.38 Billion | -222 Million | -188 Million |
| Free Cash Flow | 1.7 Billion | 914 Million | 1.31 Billion | 1.13 Billion | 1.37 Billion | -6 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 700 Million | 324 Million | 493 Million | 504 Million | 1.59 Billion | 504 Million |
| Depreciation & Amortization | 636 Million | 311 Million | 304 Million | 313 Million | 1.19 Billion | 300 Million |
| Deferred income taxes | -19 Million | -10 Million | 31 Million | 73 Million | -1 Million | -29 Million |
| Stock-based compensation | -1144.22 Billion | 195 Million | 63 Million | 59 Million | 233 Million | 59 Million |
| Change in working capital | 523 Million | -209 Million | -743 Million | -57 Million | -770 Million | -176 Million |
| Other non-cash items | -463 Million | 1.15 Billion | 14 Million | 65 Million | 253 Million | 40 Million |
| Investing Cash Flow | -1.49 Billion | -271 Million | -285 Million | -1.05 Billion | -2.57 Billion | -197 Million |
| Investments in PPE | -392 Million | -155 Million | -245 Million | -267 Million | -800 Million | -206 Million |
| Acquisitions | -847 Million | -48 Million | -47 Million | -793 Million | -1.81 Billion | 1 Million |
| Investment purchases | -125 Million | -73 Million | -66 Million | -28 Million | -55 Million | -16 Million |
| Sales/Maturities of investments | - | - | - | 28 Million | 2 Million | 15 Million |
| Other Investing Activities | -260 Million | 4 Million | -1 Million | 7 Million | 90 Million | 9 Million |
| Financing Cash Flow | 1.67 Billion | 24 Million | 1.56 Billion | 15 Million | 5 Million | 16 Million |
| Debt repayment | -22 Million | - | -1.61 Billion | -4 Million | -4 Million | -41 Million |
| Dividends payments | -23 Million | - | - | - | -28 Million | - |
| Common Stock Repurchased | -63 Million | - | 80 Million | 119 Million | 182 Million | - |
| Common Stock Issuance | 96 Million | 26 Million | 80 Million | 17 Million | 182 Million | 75 Million |
| Other Financing Activities | 1.76 Billion | -2 Million | -49 Million | 15 Million | 33 Million | 16 Million |
| Accounts receivables | -175 Million | -114 Million | -114 Million | -74 Million | -238 Million | -3 Million |
| Accounts payables | 69 Million | 71 Million | -450 Million | 23 Million | 118 Million | 17 Million |
| Inventory | -89 Million | -95 Million | -124 Million | -59 Million | -660 Million | -202 Million |
| Other working capital | -482 Million | -71 Million | -55 Million | 53 Million | 780 Million | 12 Million |
| Cash at beginning of period | 1144.62 Billion | 2.42 Billion | 1.05 Billion | 1.13 Billion | 1.12 Billion | 620 Million |
| Cash at end of period | 2.64 Billion | 2.98 Billion | 2.49 Billion | 1.05 Billion | 1.05 Billion | 1.13 Billion |
| Capital Expenditure | -392 Million | -155 Million | -245 Million | -267 Million | -800 Million | -206 Million |
| Effect of forex changes on cash | -2 Million | -1 Million | -7 Million | 4 Million | -4 Million | -5 Million |
| Net cash flow / Change in cash | -1141.97 Billion | 566 Million | 1.44 Billion | -77 Million | -71 Million | 512 Million |
| Free Cash Flow | -1143.23 Billion | 658 Million | -81 Million | 690 Million | 1.7 Billion | 492 Million |
ENZY
ACON
KEIL
PRIMEPRO
SUKHJITS
MCFT